Pfizer Inc. buy Cantor Fitzgerald
Start price
18.05.23
/
50%
€34.10
Target price
18.05.24
-
Performance (%)
-22.43%
End price
19.05.24
€26.45
Summary
This prediction ended on 19.05.24 with a price of €26.45. The price of Pfizer Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.43%. Dividends of €1.92 are taken into consideration when calculating the performance. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pfizer Inc. | -1.505% | -1.505% | 2.201% | -35.648% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten